PREPRINT (not peer reviewed)

Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Research Square
Date: 2026-05-11
Source: Europe PMC
DOI: 10.21203/rs.3.rs-9283280/v1
PubMed: Unavailable

Authors

Walters CK Chetty S Rants’o TA Gossayn S Lerotholi LJ.

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Headache / Migraine Clinical Trial Systematic Review Review Article Observational Study Treatment-Resistant Depression Safety Adverse Events Toxicity Systematic Review

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Psychedelic Therapies in the Management of Post-Traumatic Stress DisorderJournal of Education Health and Sport · 2026-07-16 Assessing Canadian Policy Readiness for Psychedelic-Assisted Therapy in Cancer CareUnknown journal · 2026-08-17 Evaluating psilocybin for the management of depression: a literature reviewBritish Journal of Mental Health Nursing · 2026-08-02 A Systematic Review of EEG Predictors and Correlates of Psilocybin’s Treatment in DepressionUndergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · 2026-07-27 Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of DepressionZenodo (CERN European Organization for Nuclear Research) · 2026-07-17 Reporting practices in psilocybin-assisted therapy trials for depression: A descriptive review and temporal overviewJournal of Psychedelic Studies · 2026-07-13 Psychedelic Therapy for DepressionUnknown journal · 2026-08-11